Updates were made to the Perinatal Guideline on January 22, 2013, January 29, 2013 and April 3, 2013. For an explanation of the updates, please see the correction notice.
(Last updated:7/31/2012; last reviewed:7/31/2012)
Key changes made to update the September 14, 2011, version of the guidelines are summarized below. Throughout the revised guidelines, significant updates are highlighted and discussed. The addendum to the guidelines—Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy—includes updated information from the Antiretroviral Pregnancy Registry and updates on recent studies of various antiretroviral agents in human pregnancy.
Lessons from Clinical Trials of Antiretroviral Interventions to Reduce Perinatal Transmission of HIV and Table 3, Results of Major Studies on Antiretroviral Prophylaxis to Prevent Mother-to-Child Transmission of HIV:
Preconception Counseling and Care for HIV-Infected Women of Childbearing Age and Table 4, Drug Interactions Between Hormonal Contraceptives and Antiretroviral Agents:
Special Considerations Regarding the Use of Antiretroviral Drugs by HIV-Infected Pregnant Women and Their Infants